Beyond antibiotics: recent developments in the diagnosis and management of nontuberculous mycobacterial infection

Laura E. Gleeson, Grant Waterer

Research output: Contribution to journalReview articlepeer-review

Abstract

Nontuberculous mycobacteria (NTM) pulmonary disease represents a significant clinical challenge with suboptimal therapy and increasing prevalence globally. Although clinical practice guidelines seek to standardise the approach to diagnosis and treatment of NTM disease, a lack of robust evidence limits their utility and significant variability exists in clinical practice. Here we walk through some novel approaches in diagnosis and therapy that are under development to tackle a disease where traditional strategies are failing.

Original languageEnglish
Article number210171
JournalBreathe
Volume18
Issue number2
DOIs
Publication statusPublished - 1 Jun 2022

Fingerprint

Dive into the research topics of 'Beyond antibiotics: recent developments in the diagnosis and management of nontuberculous mycobacterial infection'. Together they form a unique fingerprint.

Cite this